多发性骨髓瘤患者的全球差异:快速证据评估
Maria-Victoria Mateos1, Sikander Ailawadhi2, Luciano J Costa3
1University Hospital of Salamanca/IBSAL, Salamanca, Spain. mvmateos@saludcastillayleon.es.
Blood cancer journal
|July 17, 2023
概括
社会人口统计学因素在全球显著影响多发性骨髓瘤 (MM) 患者的治疗结果. 随着年龄的增长和社会经济地位的下降,结果变得更差,因此需要进一步研究健康差异.
科学领域:
- 血液学 血液学 血液学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多发性骨髓瘤 (MM) 患者的结局表现出显著的差异.
- 社会人口统计学因素与这些结果变化有关.
研究的目的:
- 评估社会人口统计学因素对MM患者结果全球差异的影响.
- 系统地分析现有的关于多发性骨髓瘤健康差异的文献.
主要方法:
- 根据PRISMA-P指南进行快速证据评估.
- 在PubMed和Embase (2011-2021) 的系统文献搜索.
- 包括/排除标准适用于84篇文章,评估年龄,性别,种族/民族,社会经济地位和地理位置.
主要成果:
- 在全球范围内,年龄较大和社会经济地位较低与MM患者的治疗结果较差有关.
- 在美国,男性的治疗结果较差,而女性和少数群体 (黑人,亚裔,西班牙裔) 面临治疗接入障碍.
- 全球差距各不相同,在美国以外没有一致的基于性别的差异.
结论:
- 这项研究强调了受MM健康差异影响的特定人群.
- 在MM患者的治疗结果中发现的差异强调了有针对性的研究的必要性.
- 进一步调查MM差异的模式,趋势和驱动因素至关重要.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
